ReviewJournal of health, population, and nutrition2025
Comprehensive narrative analysis of antimicrobial resistance in Afghanistan: key drivers, challenges, and strategic interventions.
Review in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Prioritising communicable disease research in Afghanistan: an application of the Child Health and Nutrition Research Initiative (CHNRI) methodology.BMJ global health · 2026Article
- One Health Surveillance of Antimicrobial Resistance in the Eastern Mediterranean: The Blackchin Guitarfish as a Case Study.GeoHealth · 2026Article
- Antimicrobial resistance in the Eastern Mediterranean Region: experiences, challenges, and perspectives.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntimicrobial resistance (AMR) presents a global health crisis, and Afghanistan, with its limited healthcare infrastructure, faces an acute AMR challenge. Factors such as overuse of antibiotics, unregulated drug sales, and low public awareness contribute to an accelerated spread of resistant pathogens. This study offers a comprehensive narrative analysis of the drivers of AMR in Afghanistan and proposes strategic, context-specific interventions.
methodsA narrative review was conducted using available literature and national reports to assess AMR prevalence in Afghanistan, identify contributing socio-political and healthcare challenges, and evaluate the impact of these challenges on AMR surveillance and control.
findingsHigh resistance rates are prevalent among key pathogens, including Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae, with resistance to first-line antibiotics exceeding 80% for many infections. Afghanistan's fragile healthcare infrastructure, compounded by unregulated antibiotic sales and self-medication practices, exacerbates AMR rates. Limited AMR surveillance and inadequate infection control practices further intensify the crisis.
interpretationAddressing AMR in Afghanistan requires urgent, coordinated action. Recommendations include strengthening healthcare infrastructure, enforcing antibiotic regulations, enhancing surveillance, and implementing public education campaigns. Worldwide teamwork is vital to building a resilient healthcare system to address Afghanistan's unique AMR challenges effectively. These interventions are crucial to controlling the spread of AMR and preventing a healthcare crisis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.